Thrombolysis in ST-elevation myocardial infarction is not dead
| Autoři | |
|---|---|
| Rok publikování | 2021 |
| Druh | Článek v odborném periodiku (nerecenzovaný) |
| Fakulta / Pracoviště MU | |
| Citace | |
| Popis | Primary percutaneous coronary intervention (PPCI) has been the preferred reperfusion strategy for patients with ST-elevation myocardial infarction (STEMI). However, in 2020, intravenous thrombolysis still remains a viable option for reperfusion. In European countries, long transportation time to PPCI has been the main indication for thrombolysis. Current clinical practice guidelines highlight the importance of the time interval from the first medical contact to the catheterisation laboratory admission1. If this is more than 120 minutes, a thrombolytic agent has to be administered first, followed by transport to the nearest catheterisation laboratory. |